Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL268906 | 0.89 | ESR1 (0.31) | ESR1ESR2CYP3A4TDP1 | |
| SCHEMBL269251 | 0.80 | CYP3A4 (0.35) | ESR1ESR2CYP3A4TDP1 | |
| SCHEMBL15364389 | 0.73 | ESR1 (0.32) | ESR1ESR2CYP3A4TDP1 | |
| SCHEMBL15364391 | 0.73 | ESR1 (0.32) | ESR1ESR2CYP3A4TDP1 | |
| SCHEMBL5079908 | 0.72 | ESR1 (0.31) | ESR1ESR2CYP3A4TDP1 | |
| SCHEMBL27792155 | 0.71 | — | — | |
| Hydrochloric Acid SCHEMBL4456007 | 0.70 | ATM (0.31) | ESR1ESR2CYP3A4TDP1 | |
| SCHEMBL24809381 | 0.69 | — | — | |
| SCHEMBL20343295 | 0.69 | CYP3A4 (0.31) | CYP3A4 | |
| Hydrochloric Acid SCHEMBL4456013 | 0.69 | ATM (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8134035-B2 | Preparation of asymmetric anthracene derivatives and organic electroluminescent device using same | DOOSAN CORPORATION (KR) | 2012-03-13 | — | — | US | disclosed |
| US-20110065924-A1 | PREPARATION OF ASYMMETRIC ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | DOOSAN CORPORATION (KR) | 2011-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110065924-A1 | PREPARATION OF ASYMMETRIC ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | AKR7A2, ACMSD, ALKBH3 | ESR1 1053/4885ESR2 1080/4885CYP3A4 215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.